Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74,190,609
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
18,834,753
-
Shares change
-
-716,370
-
Total reported value, excl. options
-
$18,270,940
-
Value change
-
-$1,035,142
-
Number of buys
-
20
-
Number of sells
-
-22
-
Price
-
$0.9701
Significant Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q3 2015
56 filings reported holding ENZN - ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share as of Q3 2015.
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,834,753 shares
of 74,190,609 outstanding shares and own 25% of the company stock.
Largest 10 shareholders include ICAHN CARL C (5,904,863 shares), RENAISSANCE TECHNOLOGIES LLC (3,540,084 shares), BlackRock Institutional Trust Company, N.A. (2,869,642 shares), VANGUARD GROUP INC (1,437,164 shares), UBS Group AG (743,207 shares), BlackRock Advisors LLC (714,323 shares), Connor, Clark & Lunn Investment Management Ltd. (548,521 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (357,640 shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (254,200 shares), and GLOBEFLEX CAPITAL L P (250,761 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.